Provided by Tiger Trade Technology Pte. Ltd.

Xencor

24.41
+0.15000.62%
Post-market: 24.780.3700+1.52%19:30 EDT
Volume:905.27K
Turnover:22.06M
Market Cap:1.81B
PE:-11.21
High:24.84
Open:24.72
Low:23.96
Close:24.26
52wk High:30.61
52wk Low:8.26
Shares:74.13M
Float Shares:54.25M
Volume Ratio:0.75
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1768
EPS(LYR):-1.2400
ROE:-29.07%
ROA:-16.83%
PB:3.60
PE(LYR):-19.69

Loading ...

Is Xencor (XNCR) Quietly Recasting Its Platform As A Solid-Tumor Oncology Story?

Simply Wall St.
·
Jul 19

Xencor's Cancer Drug Study Selected for Oral Presentation at ESMO; Shares Rise

MT Newswires Live
·
Jul 18

Xencor to Present Phase 1 Xmab819 Data in Advanced Kidney Cancer at ESMO 2026

Reuters
·
Jul 17

Xencor Announces Proffered Paper Oral Presentation at Esmo 2026 for Phase 1 Clinical Study of Xmab819 in Advanced Clear Cell Renal Cell Carcinoma

THOMSON REUTERS
·
Jul 17

Xencor (XNCR) Rebounds Sharply, Is It Still A Bargain?

Simply Wall St.
·
Jul 11

Xencor price target lowered to $27 from $29 at Truist

TIPRANKS
·
Jul 07

Xencor is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Xencor director Ellen Feigal disposes of 6,843 common shares worth $89,351.58

Reuters
·
Jun 23

Xencor Shareholders Approve Directors, Incentive Plan Amendments

TIPRANKS
·
Jun 19

Xencor shareholders approve 4 million-share increase under 2023 equity incentive plan

Reuters
·
Jun 19

Xencor director Alan Bruce Montgomery sells 5,064 shares worth $62,337.84

Reuters
·
Jun 18

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Jun 16

MindWalk publishes Discovery-to-Clinic presentation factsheet

Reuters
·
May 18

Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)

TIPRANKS
·
May 14

Xencor Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 12

Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)

TIPRANKS
·
May 11

Xencor price target raised to $14 from $13 at JPMorgan

TIPRANKS
·
May 11

Wedbush Remains a Buy on Xencor (XNCR)

TIPRANKS
·
May 09

Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Oscar Health (OSCR) and REPRO-MED Systems (KRMD)

TIPRANKS
·
May 07